(Q43706155)

26 November 2017

title

Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects (English)

1 reference

26 November 2017

main subject

heart rate variability

0 references

1 reference

A C Nóbrega

1

1 reference

26 November 2017

A F dos Reis

2

1 reference

26 November 2017

R S Moraes

3

1 reference

26 November 2017

B G Bastos

4

1 reference

26 November 2017

E L Ferlin

5

1 reference

26 November 2017

J P Ribeiro

6

1 reference

26 November 2017

publication date

1 February 2001

1 reference

Clinical Autonomic Research

26 November 2017

published in

1 reference

26 November 2017

volume

11

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

11-17

1 reference

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

Autonomic neural influences on the dysrhythmias resulting from myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

Opposing central and peripheral effects of atropine on parasympathetic cardiac control

21 January 2018

1 reference

12 December 2020

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

1 reference

12 December 2020

The role of enhanced vagal activity on ischemic ventricular tachycardia: Pharmacologic basis of inefficiency

1 reference

12 December 2020

Vagal stimulation after myocardial infarction: accentuating the positive

1 reference

12 December 2020

Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis

1 reference

12 December 2020

Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction

1 reference

12 December 2020

Reduction of QTc interval dispersion. Potential mechanism of cardiac protection of pyridostigmine bromide

1 reference

12 December 2020

Muscarinic receptor stimulation with edrophonium hydrochloride does not elevate ventricular fibrillation thresholds in humans

1 reference

12 December 2020

Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation

1 reference

12 December 2020

Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control

1 reference

12 December 2020

Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies

1 reference

12 December 2020

Influence of heart rate on mortality after acute myocardial infarction

1 reference

12 December 2020

Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction

1 reference

12 December 2020

Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors

1 reference

12 December 2020

Influence of transdermal scopolamine on cardiac sympathovagal interaction after acute myocardial infarction

1 reference

12 December 2020

Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials

1 reference

12 December 2020

Autonomic nervous system adaptations to short-term exercise training

1 reference

12 December 2020

Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans

1 reference

12 December 2020

Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress.

1 reference

12 December 2020

Three-dimensional return map: a new tool for quantification of heart rate variability

1 reference

12 December 2020

Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification

1 reference

12 December 2020

Termination of ventricular tachycardia by an increase in cardiac vagal drive

1 reference

12 December 2020

Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction

1 reference

12 December 2020

Exercise training after experimental myocardial infarction increases the ventricular fibrillation threshold before and after the onset of reinfarction in the isolated rat heart

1 reference

12 December 2020

Pyridostigmine blunts the increases in myocardial oxygen demand elicited by the stimulation of the central nervous system in anesthetized rats.

1 reference

12 December 2020

Components of heart rate variability--what they really mean and what we really measure

1 reference

12 December 2020

Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: quantification by spectral analysis of heart rate fluctuations in healthy human beings

1 reference

12 December 2020

Acetylcholinesterase inhibitor, pyridostigmine bromide, reduces skin blood flow in humans

1 reference

12 December 2020

Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia

1 reference

12 December 2020

Parasympathetic dysfunction as a risk factor in myocardial infarction: what is the treatment?

1 reference

12 December 2020

Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction

1 reference

12 December 2020

Bradycardia produced by pyridostigmine and physostigmine.

1 reference

12 December 2020

Sympathetic nervous system representation in time and frequency domain indices of heart rate variability

1 reference

12 December 2020

Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure

1 reference

12 December 2020

Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction.

1 reference

12 December 2020

The effects of psychological stress and vagal stimulation with morphine on vulnerability to ventricular fibrillation (VF) in the conscious dog.

1 reference

12 December 2020

Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease

1 reference

12 December 2020

Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine

1 reference

12 December 2020

Pyridostigmine bromide does not alter thermoregulation during exercise in cold air

1 reference

12 December 2020

How important is heart rate?

1 reference

12 December 2020

Pharmacokinetics and oral bioavailability of pyridostigmine in man

1 reference

12 December 2020

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

1 reference

12 December 2020

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

1 reference

12 December 2020

Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine

1 reference

12 December 2020

Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction.

1 reference

12 December 2020

Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine.

1 reference

12 December 2020

Effect of partial arrhythmia suppression with amiodarone on heart rate variability of patients with congestive heart failure

1 reference

12 December 2020

Cholinergic stimulation with pyridostigmine, hemodynamic and echocardiographic analysis in healthy subjects

1 reference

12 December 2020

Effect of a 'vagomimetic' atropine dose on canine cardiac vagal tone and susceptibility to sudden cardiac death.

1 reference

12 December 2020

Scopolamine improves autonomic balance in advanced congestive heart failure

1 reference

12 December 2020

Measurement of acetylcholinesterase in erythrocytes in the field.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02317797

1 reference

Dimensions Publication ID

26 November 2017

1021336141

0 references

1 reference